- Home
- HURC vs HURA Comparison
HURC vs HURA Comparison
Compare HURC & HURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HURC
- HURA
- Stock Information
- Founded
- HURC 1968
- HURA 2009
- Country
- HURC United States
- HURA United States
- Employees
- HURC N/A
- HURA N/A
- Industry
- HURC Industrial Machinery/Components
- HURA
- Sector
- HURC Industrials
- HURA
- Exchange
- HURC Nasdaq
- HURA Nasdaq
- Market Cap
- HURC 125.1M
- HURA 122.0M
- IPO Year
- HURC N/A
- HURA N/A
- Fundamental
- Price
- HURC $18.22
- HURA $3.06
- Analyst Decision
- HURC
- HURA Strong Buy
- Analyst Count
- HURC 0
- HURA 2
- Target Price
- HURC N/A
- HURA $11.50
- AVG Volume (30 Days)
- HURC 24.1K
- HURA 778.4K
- Earning Date
- HURC 09-05-2025
- HURA 08-14-2025
- Dividend Yield
- HURC N/A
- HURA N/A
- EPS Growth
- HURC N/A
- HURA N/A
- EPS
- HURC N/A
- HURA N/A
- Revenue
- HURC $183,634,000.00
- HURA N/A
- Revenue This Year
- HURC N/A
- HURA N/A
- Revenue Next Year
- HURC N/A
- HURA N/A
- P/E Ratio
- HURC N/A
- HURA N/A
- Revenue Growth
- HURC N/A
- HURA N/A
- 52 Week Low
- HURC $13.19
- HURA $1.80
- 52 Week High
- HURC $23.76
- HURA $8.63
- Technical
- Relative Strength Index (RSI)
- HURC 43.94
- HURA N/A
- Support Level
- HURC $18.00
- HURA N/A
- Resistance Level
- HURC $19.34
- HURA N/A
- Average True Range (ATR)
- HURC 0.65
- HURA 0.00
- MACD
- HURC -0.21
- HURA 0.00
- Stochastic Oscillator
- HURC 10.97
- HURA 0.00
About HURC Hurco Companies Inc.
Hurco Companies Inc is a United States-based industrial technology company. It designs, manufactures, and sells computerized machine tools, consisting mainly of vertical machining centers and turning centers, to companies in the metalworking industry through sales, service, and distribution networks. The company concentrated on designing user-friendly computer control systems that both skilled and unskilled machine tool operators can operate. It generates maximum revenue from the Computerized Machine Tools product. Geographically, It derives a majority of its revenue from the United States of America. Its product categories include 5-Axis VMC; 3-Axis VMC; Horizontal MC and Turning Centers.
About HURA TuHURA Biosciences Inc. Common Stock
TuHURA Biosciences Inc is a Phase 3 registration stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. It is preparing to initiate a single randomized placebo-controlled Phase 3 registration trial of IFx-2.0 administered as an adjunctive therapy to Keytruda (pembrolizumab) in first-line treatment for advanced or metastatic Merkel Cell Carcinoma.